News
PiKe Pharma is the coordinator of the ongoing FP7 project “FLUINHIBIT” worth 1.5 million Euro.
Pike Pharma has been awarded a prize for one of the best business ideas in the “Venture 2008” competition of McKinsey and the ETH Zürich.
PiKe Pharma is the coordinator of the ongoing FP7 project “FLUINHIBIT” worth 1.5 million Euro.
Pike Pharma has been awarded a prize for one of the best business ideas in the “Venture 2008” competition of McKinsey and the ETH Zürich.